AAAAAA

   
Results: 1-12 |
Results: 12

Authors: Pisters, KMW Newman, RA Coldman, B Shin, DM Khuri, FR Hong, WK Glisson, BS Lee, JS
Citation: Kmw. Pisters et al., Phase I trial of oral green tea extract in adult patients with solid tumors, J CL ONCOL, 19(6), 2001, pp. 1830-1838

Authors: Pisters, KMW
Citation: Kmw. Pisters, Adjuvant and neoadjuvant therapy for early stage non-small cell lung cancer, SEMIN ONCOL, 28(4), 2001, pp. 23-28

Authors: Pisters, KMW
Citation: Kmw. Pisters, The role of chemotherapy in early-stage (stage I and II) resectable non-small cell lung cancer, SEM RAD ONC, 10(4), 2000, pp. 274-279

Authors: Yen, N Ioannides, CG Xu, K Swisher, SG Lawrence, DD Kemp, BL El-Naggar, AK Cristiano, RJ Fang, BL Glisson, BS Hong, WK Khuri, FR Kurie, JM Lee, JJ Lee, JS Merritt, JA Mukhopadhyay, T Nesbitt, JC Nguyen, D Perez-Soler, R Pisters, KMW Putnam, JB Schrump, DS Shin, DM Walsh, GL Roth, JA
Citation: N. Yen et al., Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type p53 (Ad-p53), CANC GENE T, 7(4), 2000, pp. 530-536

Authors: Nemunaitis, J Swisher, SG Timmons, T Connors, D Mack, M Doerksen, L Weill, D Wait, J Lawrence, DD Kemp, BL Fossella, F Glisson, BS Hong, WK Khuri, FR Kurie, JM Lee, JJ Lee, JS Nguyen, DM Nesbitt, JC Perez-Soler, R Pisters, KMW Putnam, JB Richli, WR Shin, DM Walsh, GL Merritt, J Roth, J
Citation: J. Nemunaitis et al., Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumorsof patients with non-small-cell lung cancer, J CL ONCOL, 18(3), 2000, pp. 609-622

Authors: Pisters, KMW Ginsberg, RJ Giroux, DJ Putnam, JB Kris, MG Johnson, DH Roberts, JR Mault, J Crowley, JJ Bunn, PA
Citation: Kmw. Pisters et al., Induction chemotherapy before surgery for early-stage lung cancer: A novelapproach, J THOR SURG, 119(3), 2000, pp. 429-437

Authors: Swisher, SG Roth, JA Nemunaitis, J Lawrence, DD Kemp, BL Carrasco, CH Connors, DG El-Naggar, AK Fossella, F Glisson, BS Hong, WK Khuri, FR Kurie, JM Lee, JJ Lee, JS Mack, M Merritt, JA Nguyen, DM Nesbitt, JC Perez-Soler, R Pisters, KMW Putnam, JB Richli, WR Savin, M Schrump, DS Shin, DM Shulkin, A Walsh, GL Wait, J Weill, D Waugh, MKA
Citation: Sg. Swisher et al., Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer, J NAT CANC, 91(9), 1999, pp. 763-771

Authors: Pizzo, BA Pisters, KMW Miller, VA Grant, SC Baltzer, L Hinckley, L Kris, MG
Citation: Ba. Pizzo et al., Oral cisapride for the control of delayed vomiting following high-dose cisplatin, SUPP CARE C, 7(1), 1999, pp. 44-46

Authors: Rigas, JR Kris, MG Miller, VA Pisters, KMW Heelan, RT Grant, SC Fennelly, DW Chou, TC Sirotnak, FM
Citation: Jr. Rigas et al., Phase I study of the sequential administration of edatrexate and paclitaxel in patients with advanced solid tumors, ANN ONCOL, 10(5), 1999, pp. 601-603

Authors: Glisson, BS Kurie, JM Perez-Soler, R Fox, NJ Murphy, WK Fossella, FV Lee, JS Ross, MB Nyberg, DA Pisters, KMW Shin, DM Hong, WK
Citation: Bs. Glisson et al., Cisplatin, etoposide, and paclitaxel in the treatment of patients with extensive small-cell lung carcinoma, J CL ONCOL, 17(8), 1999, pp. 2309-2315

Authors: Ng, KK Kris, MG Ginsberg, RJ Heelan, RT Pisters, KMW Miller, VA Grant, SG Bains, M Rusch, V Rosenzweig, KE Martini, N
Citation: Kk. Ng et al., Induction chemotherapy employing dose-intense cisplatin with mitomycin andvinblastine (MVP400), followed by thoracic surgery or irradiation, for patients with stage III nonsmall cell lung carcinoma, CANCER, 86(7), 1999, pp. 1189-1197

Authors: Shade, RJ Pisters, KMW Huber, MH Fossella, F Perez-Soler, R Shin, DM Kurie, J Glisson, B Lippman, S Lee, JS
Citation: Rj. Shade et al., Phase I study of paclitaxel administered by ten-day continuous infusion, INV NEW DR, 16(3), 1998, pp. 237-243
Risultati: 1-12 |